Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Organon & Co.OGN · Entity 4115 | Head of Ext. Affairs and ESG | May 04, 2023 | May 08, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Organon & Co.
Report date May 04, 2023 · Filed May 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,755 |
Ending reported balance
After 2023-05-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-05-04 · Exercise / conversion · Acquired 1,939 · Balance 11,420 F1: 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. Row 2 · 2023-05-04 · Tax withholding · Disposed 665 · Balance 10,755 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2024-05-04 | Direct | 1,940 |
Reported balance
After 2023-05-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-05-04 · Exercise / conversion · Disposed 1,939 · Balance 1,940 F1: 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2023 Filed May 8, 2023 22:45 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 1,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028103 · doc4.xml · derivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,940 Underlying: Common Stock · 1,939 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. F1 · derivative.exercise_date: 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. F1 · derivative.expiration_date: 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:45 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 665 | $24.24 | $16,119.60 |
DisclosureSEC source: 0001209191-23-028103 · doc4.xml · nonDerivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,755 Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:45 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 1,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-028103 · doc4.xml · nonDerivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. Read SEC document |
| May 01, 2023 Filed May 3, 2023 23:08 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 977 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027176 · doc4.xml · derivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 977 shares Expires 2023-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested. Read SEC document |
| May 01, 2023 Filed May 3, 2023 23:08 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 335 | $24.63 | $8,251.05 |
DisclosureSEC source: 0001209191-23-027176 · doc4.xml · nonDerivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,481 Read SEC document |
| May 01, 2023 Filed May 3, 2023 23:08 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 977 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-027176 · doc4.xml · nonDerivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:19 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (right to buy) · Derivative | 41,984 | $0.00 Strike: $23.52 | $0.00 |
DisclosureSEC source: 0001209191-23-023084 · doc4.xml · derivative · entry 4 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,984 Underlying: Common Stock · 41,984 shares Expires 2033-03-31 F4 · derivative.exercise_date: The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:19 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023084 · doc4.xml · derivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,817 Underlying: Common Stock · 1,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. F3 · derivative.exercise_date: On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025. F3 · derivative.expiration_date: On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:19 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 654 | $23.09 | $15,100.86 |
DisclosureSEC source: 0001209191-23-023084 · doc4.xml · nonDerivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,839 Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:19 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 1,908 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-023084 · doc4.xml · nonDerivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into one share of Organon & Co. common stock. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:35 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 4,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014868 · doc4.xml · derivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,102 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into one share of Organon & Co. common stock. F2 · date: As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023. F2 · derivative.exercise_date: As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023. F2 · derivative.expiration_date: As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:35 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 1,543 | $25.09 | $38,713.87 |
DisclosureSEC source: 0001209191-23-014868 · doc4.xml · nonDerivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:35 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 4,102 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-014868 · doc4.xml · nonDerivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Head of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into one share of Organon & Co. common stock. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:50 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 1,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · derivative · entry 6 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,939 Underlying: Common Stock · 1,939 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F2 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:50 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 665 | $32.44 | $21,572.60 |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · nonDerivative · entry 4 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,026 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:50 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 1,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · nonDerivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:50 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 684 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · derivative · entry 5 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684 Underlying: Common Stock · 684 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:50 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 235 | $32.08 | $7,538.80 |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · nonDerivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,752 Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:50 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · nonDerivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 01, 2022 Filed May 3, 2022 23:42 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 974 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055433 · tm2214297-7_4seq1.xml · derivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974 Underlying: Common Stock · 974 shares Expires 2023-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023. F2 · shares: The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023. Read SEC document |
| May 01, 2022 Filed May 3, 2022 23:42 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 334 | $32.33 | $10,798.22 |
DisclosureSEC source: 0001104659-22-055433 · tm2214297-7_4seq1.xml · nonDerivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,303 Read SEC document |
| May 01, 2022 Filed May 3, 2022 23:42 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 974 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-055433 · tm2214297-7_4seq1.xml · nonDerivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:10 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (right to buy) · Derivative | 17,636 | $0.00 Strike: $34.93 | $0.00 |
DisclosureSEC source: 0001104659-22-042362 · tm2211465-7_4seq1.xml · derivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,636 Underlying: Common Stock · 17,636 shares Expires 2032-03-29 F3 · derivative.exercise_date: The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:10 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 5,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042362 · tm2211465-7_4seq1.xml · derivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,725 Underlying: Common Stock · 5,725 shares Expires 2025-03-31 F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · derivative.exercise_date: These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:44 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 3,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-029452 · tm228175-2_4seq1.xml · derivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,777 shares Expires 2021-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit converts into one share of Organon & Co. common stock. F2 · date: As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022. F3 · shares: The amount of the Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. F2 · derivative.exercise_date: As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022. F2 · derivative.expiration_date: As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:44 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 1,366 | $37.57 | $51,320.62 |
DisclosureSEC source: 0001104659-22-029452 · tm228175-2_4seq1.xml · nonDerivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,663 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:44 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 3,777 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-029452 · tm228175-2_4seq1.xml · nonDerivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converts into one share of Organon & Co. common stock. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:04 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (Right to Buy) · Derivative | 22,321 | $0.00 Strike: $35.38 | $0.00 |
DisclosureSEC source: 0000899243-21-033664 · doc4.xml · derivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,321 Underlying: Common Stock · 22,321 shares Expires 2031-08-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on August 17, 2022, August 17, 2023 and August 17, 2024. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (Right to Buy) · Derivative | 45,104 | $0.00 Strike: $36.11 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 14 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,104 Underlying: Common Stock · 45,104 shares Expires 2031-05-03 F9 · kind: In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. F12 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (Right to Buy) · Derivative | 22,887 | $0.00 Strike: $36.91 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 13 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,887 Underlying: Common Stock · 22,887 shares Expires 2030-04-30 F9 · kind: In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. F11 · derivative.exercise_date: 7,627 shares underlying the option are fully vested. The remaining shares vest and become exercisable in two equal installments on May 1, 2022 and May 1, 2023. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (Right to Buy) · Derivative | 15,446 | $0.00 Strike: $38.01 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 12 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,446 Underlying: Common Stock · 15,446 shares Expires 2029-05-02 F9 · kind: In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. F10 · derivative.exercise_date: 10,296 shares underlying the option are fully vested. The remaining shares vest and become exercisable on May 3, 2022. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (Right to Buy) · Derivative | 16,022 | $0.00 Strike: $27.44 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 11 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,022 Underlying: Common Stock · 16,022 shares Expires 2028-05-03 F9 · kind: In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (Right to Buy) · Derivative | 21,835 | $0.00 Strike: $25.98 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 10 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,835 Underlying: Common Stock · 21,835 shares Expires 2026-05-09 F9 · kind: In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (Right to Buy) · Derivative | 52,132 | $0.00 Strike: $28.44 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 9 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,132 Underlying: Common Stock · 52,132 shares Expires 2025-04-30 F9 · kind: In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantStock Option (Right to Buy) · Derivative | 23,170 | $0.00 Strike: $27.67 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 8 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,170 Underlying: Common Stock · 23,170 shares Expires 2024-05-01 F9 · kind: In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 7,710 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 7 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,710 Underlying: Common Stock · 7,710 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Organon common stock. F6 · kind: In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. F8 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Organon common stock in a single installment on December 31, 2023. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 4,102 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 6 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,102 Underlying: Common Stock · 4,102 shares Expires 2022-12-31 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Organon common stock. F6 · kind: In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. F7 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Organon common stock in a single installment on December 31, 2022. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 3,776 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 5 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,776 Underlying: Common Stock · 3,776 shares Expires 2021-12-31 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Organon common stock. F6 · kind: In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 5,818 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 4 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,818 Underlying: Common Stock · 5,818 shares Expires 2024-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Organon common stock. F3 · kind: In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 1,951 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,951 Underlying: Common Stock · 1,951 shares Expires 2023-05-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Organon common stock. F3 · kind: In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Organon common stock in two equal installments on May 1, 2022 and May 1, 2023. Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 01:17 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 684 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-022185 · doc4.xml · derivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684 Underlying: Common Stock · 684 shares Expires 2022-05-03 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Organon common stock. F3 · kind: In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.